Evolent Health Inc.

About Evolent Health Inc.

Evolent is a specialty care management company focused on improving health outcomes and affordability across the member experience for health plans. They aim to ensure every person receives the same quality of care they would want for their loved ones, working across various medical specialties and primary care to enhance the care journey for patients with conditions like cancer, cardiovascular diseases, and musculoskeletal disorders.

Products & Services

Oncology:Helps patients access up-to-date, high-quality treatment pathways with clinical pathways, decision support, and provider/patient engagement.

Cardiology:Identifies the best services and ensures alignment with treatment and testing guidelines.

Musculoskeletal:Increases high-value pain management and surgery procedures in appropriate settings.

Primary Care:Improves quality while managing costs in an ACO for independent providers.

Administrative Services:Streamlines operations and improves the member experience with an aligned partner.

Advanced Illness:Empowers people nearing the end of life to receive care that respects their goals and preferences.

Genetic Testing:Ensures health plan members get the most appropriate tests to guide decision-making.

Physical Medicine:Manages chiropractic, physical therapy, occupational therapy, and speech therapy services.

Radiology:Ensures imaging studies provide insights to patient care while minimizing radiation safety risks.

Surgical Management:Increases the value of surgical procedures by optimizing device selection and site of care.

Cancer Care Member Navigation:A comprehensive program combining personalized support and a digital platform for a connected, empowered experience for health plan members with cancer.

Specialties

Oncology Cardiology Musculoskeletal Care Primary Care Advanced Illness Care Genetic Testing Physical Medicine Radiology Surgical Management Specialty Care Management

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Senior Notes T: - FT: Convertible Senior Notes	A: 145000000 MR: - FA: $145.0 million FAN: 145000000	D: 2025-08-19 FD: 2025-08-19	-
2	RT: Convertible Debt T: - FT: Convertible Debt	A: 140000000 MR: - FA: 140.0 million FAN: 140000000	D: 2025-08-18 FD: 2025-08-18	-
3	RT: Debt T: - FT: Debt	A: 350000000 MR: - FA: $350.0 million FAN: 350000000	D: 2023-12-05 FD: 2023-12-05	-

Convertible Senior Notes Latest

2025-08-19

$145.0M

Convertible Debt 2025-08-18

$140.0M

Debt 2023-12-05

$350.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amy Cripps

Healthcare Consultant

S

Samir Dalia

Attending Physician, Mercy Clinic-Joplin Oncology and Hematology

S

Seth Hardy

Associate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical Center

S

Scott Kruger

Medical Director, Virginia Oncology Associates

M

Mohit Narang

Managing Partner, Maryland Oncology Hematology

L

Lisa Raff

Vice President of Pharmacy Services, OneOncology

View 49 more team members with Pro

Unlock Full Team Directory

Recent News